JDJulien Dubreucq

Julien Dubreucq

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julien Dubreucq has a total of 402 co-authors. Here are the top co-authors by number of shared publications:

  • Isabelle Chereau

    Department of Psychiatry, UMR, CHU Clermont-Ferrand, University of Clermont Auvergne, Institut Pascal, Clermont-Ferrand, France

    6 shared publications
  • Bruno Aouizerate

    Fondation FondaMental, Créteil, France; Centre Hospitalier Charles Perrens, Pôle PGU, Laboratoire de psychologie LabPsy UR4139, Université de Bordeaux, Bordeaux, France

    5 shared publications
  • Sylvain Leignier

    Fondation FondaMental, Creteil, France

    5 shared publications
  • Caroline Dubertret

    Department of Psychiatry, Louis-Mourier Hospital, AP-HP, Colombes, France

    4 shared publications
  • Catherine Massoubre

    TAPE Research Unit ‐ Eating Disorders, Addictions & Extreme Bodyweight University Jean Monnet Saint‐Etienne, University Hospital Saint‐Etienne Saint‐Etienne France

    4 shared publications
  • Fabrice Berna

    Fondation FondaMental, Creteil, France

    4 shared publications

Latest Publications

  • Auto-stigmatisation dans les troubles psychiques sévères et persistants

    by Julien Dubreucq

    L’auto-stigmatisation est fréquente chez les personnes avec Troubles Psychiques Sévères et Persistants (TPSP), dont elle altère le devenir clinique et fonctionnel. L’objectif de ce travail était de définir plus précisément l’auto-stigmatisation dans les TPSP et de mieux identifier les moyens d’y faire face. Il comporte plusieurs étapes : i) une 1ère revue systématique de littérature pour mieux appréhender les mécanismes cognitifs et neurobiologiques potentiels sous-tendant les effets de la stigmatisation; ii) une 2nde revue systématique de littérature sur la prévalence, les prédicteurs et les conséquences de l’auto-stigmatisation dans les TPSP ; iii) l’étude de la fréquence de l’auto-stigmatisation et de la résistance à la stigmatisation et des corrélats d’une auto-stigmatisation ou d’une résistance élevée à la stigmatisation dans la cohorte nationale des centres référents de réhabilitation psychosociale (REHABase), décrite dans un 1er article ; iv) l’adaptation française du programme de thérapie cognitive et de renforcement narratif (NECT) et un essai randomisé contrôlé évaluant son efficacité sur le fonctionnement social dans les TPSP, débutant au 1er trimestre 2020. L’auto-stigmatisation est un problème majeur de santé publique, et ce quelque soit l’aire géographique et culturelle, la pathologie ou le stade évolutif considérés. Environ 1/3 des participants de la cohorte REHABase ont une auto-stigmatisation élevée, celle-ci étant associée aux stades précoces du rétablissement et à un bien être et une satisfaction dans les relations sociales altérés. La résistance à la stigmatisation concerne plus de 50% des participants et est favorisée par la satisfaction dans les relations familiales. Ce travail a plusieurs implications cliniques et pour la recherche, discutées de façon approfondie

  • Open Access

    Evaluation of a pro-recovery training intervention (REFOCUS-RETAFORM) in specialist mental health services across France: stepped-wedge cluster randomised controlled trial protocol

    by Julien Dubreucq, Nicolas Franck, Julien Plasse, Anne-Elisabeth Muller, Marie-Cécile Bralet, Céline Bera-Potelle, Fabrice Berna, Clara Blachère, Alexandre Carpentier, Isabelle Chereau, et al.

    While recovery orientation is national policy in many countries, evidence remains limited for the effectiveness at a service level. This paper describes the protocol for implementing a pro-recovery training intervention (REFOCUS-RETAFORM) in specialist mental health services across France. The aim is to evaluate whether REFOCUS-RETAFORM plus usual care leads to improved outcomes for adolescent and adult mental health service users compared with usual care alone. A two-step stepped wedge cluster randomised controlled trial will be conducted, with a nested qualitative sub-study exploring stakeholders’ views on changes in staff-user relationships and implementation influences. The REFOCUS-RETAFORM intervention is a training intervention for mental health staff, to develop recovery-promoting relationships and pro-recovery working practices. Clusters are services, which transition sequentially from control to intervention condition in a randomised order. Eight clusters are randomised to deliver REFOCUS-RETAFORM in year one and eight clusters in year two. Each cluster delivers REFOCUS-RETAFORM to two teams from their organisation (32 teams in total). Participants are a) service users aged 13–65 years attending services implementing REFOCUS-RETAFORM, and b) staff receiving the intervention. The primary outcome is the Questionnaire about the Process of Recovery. Secondary outcomes include perceived stigma and coercion, self-stigma and wellbeing for service users, and recovery-orientation for staff. Data will be collected from 540 service users (180 at baseline, 180 at month 12, 180 at month 24) and 220 staff. We will use multilevel mixed-effects models, adjusting for secular trends and thematic analysis for the qualitative interview data. Findings will inform the continued transformation of French specialist mental health services toward a recovery orientation. Clinical Trials NCT05824234, registered 21 April 2023.


  • Open Access

    School refusal: what if it’s an autism spectrum disorder? A scoping review

    by Camille Escoffier, Valérie Rousselon-Charles, Julien Dubreucq, Rodolphe Charles


  • Open Access

    A systematic review of midwives’ training needs in perinatal mental health and related interventions

    by Marine Dubreucq, Corinne Dupont, Mijke P. Lambregtse-Van Den Berg, Wichor M. Bramer, Catherine Massoubre, Julien Dubreucq

    Background: Midwives may be key stakeholders to improve perinatal mental healthcare (PMHC). Three systematic reviews considered midwives’ educational needs in perinatal mental health (PMH) or related interventions with a focus on depression or anxiety. This systematic review aims to review: 1) midwives’ educational/training needs in PMH; 2) the training programs in PMH and their effectiveness in improving PMHC.Methods: We searched six electronic databases using a search strategy designed by a biomedical information specialist. Inclusion criteria were: (1) focus on midwives; (2) reporting on training needs in PMH, perinatal mental health problems or related conditions or training programs; (3) using quantitative, qualitative or mixed-methods design. We used the Mixed Methods Appraisal Tool for study quality.Results: Of 4969 articles screened, 66 papers met eligibility criteria (47 on knowledge, skills or attitudes and 19 on training programs). Study quality was low to moderate in most studies. We found that midwives’ understanding of their role in PMHC (e.g. finding meaning in opening discussions about PMH; perception that screening, referral and support is part of their routine clinical duties) is determinant. Training programs had positive effects on proximal outcomes (e.g. knowledge) and contrasted effects on distal outcomes (e.g. number of referrals).Conclusions: This review generated novel insights to inform initial and continuous education curriculums on PMH (e.g. focus on midwives’ understanding on their role in PMHC or content on person-centered care).Registration details: The protocol is registered on PROSPERO (CRD42021285926)


  • Open Access

    Postpartum blues: a predictor of postpartum depression, from the IGEDEPP Cohort

    by Alexandra Landman, Elodie Gaelle Ngameni, Marine Dubreucq, Julien Dubreucq, Igedepp Groups, Sarah Tebeka, Caroline Dubertret

    Background: To identify the different factors associated with postpartum blues and its association with postpartum depression, from a large French cohort. Methods: We conducted an analysis of the Interaction Gene Environment in Postpartum Depression cohort, which is a prospective, multicenter cohort including 3310 women. Their personal (according to the Diagnostic and Statistical Manual, fifth edition [DSM-5]) and family psychiatric history, stressful life events during childhood, pregnancy, and delivery were collected. Likewise, the French version of the Maternity Blues Scale questionnaire was administered at the maternity department. Finally, these women were assessed at 8 weeks and 1 year postpartum by a clinician for postpartum depression according to DSM-5 criteria. Results: The prevalence of postpartum blues in this population was 33%, and significant factors associated with postpartum blues were found as personal (aOR = 1.2) and family psychiatric history (aOR = 1.2), childhood trauma (aOR = 1.3), obstetrical factors, or events related to the newborn, as well as an experience of stressful life events during pregnancy (aOR = 1.5). These factors had a cumulative effect, with each additional factor increasing the risk of postpartum blues by 31%. Furthermore, adjustment for sociodemographic measures and history of major depressive episode revealed a significant association between postpartum blues and postpartum depression, mainly at early onset, within 8 weeks after delivery (aOR = 2.1; 95% CI = 1.6–2.7), but also at late onset (aOR = 1.4; 95% CI = 1.1–1.9), and mainly if the postpartum blues is severe. Conclusion: These results justify raising awareness among women with postpartum blues, including reassurance and information about postpartum depression, its symptomatology, and the need for management in case of worsening or prolongation of postpartum blues.


  • Open Access

    Toward recovery-oriented perinatal healthcare: A participatory qualitative exploration of persons with lived experience and health providers’ views and experiences

    by Marine Dubreucq, Mathilde Thiollier, Sarah Tebeka, Pierre Fourneret, Marion Leboyer, Sylvie Viaux-Savelon, Catherine Massoubre, Corinne Dupont, Julien Dubreucq

    Background: Perinatal mental health disorders (PMHD) remain often undetected, undiagnosed, and untreated with variable access to perinatal mental health care (PMHC). To guide the design of optimal PMHC (i.e., coproduced with persons with lived experience [PLEs]), this qualitative participatory study explored the experiences, views, and expectations of PLEs, obstetric providers (OP), childcare health providers (CHPs), and mental health providers (MHPs) on PMHC and the care of perinatal depression. Methods: We conducted nine focus groups and 24 individual interviews between December 2020 and May 2022 for a total number of 84 participants (24 PLEs; 30 OPs; 11 CHPs; and 19 MHPs). The PLEs group included women with serious mental illness (SMI) or autistic women who had contact with perinatal health services. We recruited PLEs through social media and a center for psychiatric rehabilitation, and health providers (HPs) through perinatal health networks. We used the inductive six-step process by Braun and Clarke for the thematic analysis. Results: We found some degree of difference in the identified priorities between PLEs (e.g., personal recovery, person-centered care) and HPs (e.g., common culture, communication between providers, and risk management). Personal recovery in PMHD corresponded to the CHIME framework, that is, connectedness, hope, identity, meaning, and empowerment. Recovery-supporting relations and peer support contributed to personal recovery. Other factors included changes in the socio-cultural conception of the peripartum, challenging stigma (e.g., integrating PMH into standard perinatal healthcare), and service integration. Discussion: This analysis generated novel insights into how to improve PMHC for all users including those with SMI or autism.


  • Open Access

    Examining the evidence on complementary and alternative therapies to treat peripartum depression in pregnant or postpartum women: study protocol for an umbrella review of systematic reviews and meta-analyses

    by Julien Dubreucq, Astrid M Kamperman, Nadia Al-Maach, Wichor M Bramer, Francisca Pacheco, Ana Ganho-Avila, Mijke Lambregtse-Van Den Berg

    Introduction Complementary and alternative therapies (CATs) refer to a diverse range of approaches that can be used as add-on or an alternative to conventional therapies. While a number of individual studies and systematic reviews (SRs) or meta-analyses (MAs) have investigated the effectiveness of specific types of CATs to treat depressive symptoms at specific moments of the perinatal period, an overarching synthesis of the literature is currently lacking. We will conduct an umbrella review of SRs and MAs to assess to which extent CATs are associated with depressive symptoms reduction during pregnancy or after childbirth. Methods and analysis We will search a broad set of electronic databases (MEDLINE via Ovid, Embase.com, CINAHL via EBSCOhost, PsycINFO via Ovid, AMED and Google Scholar). We will include SRs with or without MAs meeting the following criteria: (1) the review should focus mostly on individual studies reporting a randomised controlled design; (2) diagnosis should be made during pregnancy or during the post partum using a clinical interview according to DSM or ICD criteria; (3) the reviewed intervention should start during pregnancy or in the first postpartum year and meet the criteria for being considered as CAT. The main outcome will be depressive symptoms reduction during pregnancy or after childbirth. Secondary outcomes will include the remission of depression according to DSM criteria and intervention acceptability. Overlap between reviews will be described, quantified and discussed. We will rate the quality of the included SRs or MAs using the AMSTAR-2 tool. MAs will be performed by using the data from the individual RCT studies included in the SRs or MAs. Sensitivity analyses restricted to studies with a low-moderate risk of bias will be realised. Publication bias will be examined visually by using a funnel plot, and formally using the Egger’s test and test of excess significance. Ethics and dissemination We intend to publish the results of the umbrella review in an international peer-reviewed journal. Oral presentations in congresses and internal diffusion through the Rise up-PPD European COST Action network are also planned. PROSPERO registration number CRD42021229260.


  • Gender differences in psychosocial function and self-reported health status in late-diagnosed autistic adults: results from the FACE-ASD national cohort

    by Julien Dubreucq, Romain Coutelle, Mohamed Lajnef, Ophélia Godin, Anouck Amestoy, Paola Atzori, Jean-Marc Baleyte, Olivier Bonnot, Manuel Bouvard, Nathalie Coulon, et al.

    Background: While adult outcome in autism spectrum disorder (ASD) is generally measured using socially valued roles, it could also be understood in terms of aspects related to health status – an approach that could inform on potential gender differences.Methods: We investigated gender differences in two aspects of outcome related to health-status, i.e. general functioning and self-perceived health status, and co-occurring health conditions in a large multi-center sample of autistic adults. Three hundred and eighty-three participants were consecutively recruited from the FondaMental Advanced Centers of Expertise for ASD cohort (a French network of seven expert centers) between 2013 and 2020. Evaluation included a medical interview, standardized scales for autism diagnosis, clinical and functional outcomes, self-perceived health status and verbal ability. Psychosocial function was measured using the Global Assessment of Functioning scale.Results: While autistic women in this study were more likely than men to have socially valued roles, female gender was associated with poorer physical and mental health (e.g. a 7-fold risk for having three or more co-occurring physical health conditions) and a poorer self-perceived health status. Psychosocial function was negatively associated with depression and impairment in social communication. Half of the sample had multiple co-occurring health conditions but more than 70% reported that their visit at the Expert Center was their first contact with mental health services.Conclusions: To improve objective and subjective aspects of health outcome, gender differences and a wide range of co-occurring health conditions should be taken into account when designing healthcare provision for autistic adults.


  • Contrasting the Social Cognitive and Metacognitive Capacities Among Patients With Schizophrenia and Autism Spectrum Disorders Enrolled in Psychiatric Rehabilitation

    by Julien Dubreucq, Aude Martin, Franck Msc Gabayet, Julien Msc Plasse, Courtney Msc Wiesepape, Clélia Quilès, Hélène Verdoux, Nicolas Franck, Paul H. Lysaker

    Unique deficits in synthetic metacognition have been found in schizophrenia when compared with other psychiatric conditions and community controls. Although persons with autism spectrum disorders (ASD) display similar deficits in social cognition relative to those with schizophrenia, to date no study has compared metacognitive function between these groups. We aimed to compare the metacognitive capacities of persons with schizophrenia and ASD and their associations with other outcomes (neurocognition, social cognition, depression, and quality of life). Fifty-six outpatients with schizophrenia or ASD (mean age, 32.50 [9.05]; 67.9% male) were recruited from two French Centers of Reference for Psychiatric Rehabilitation of the REHABase cohort. Evaluation included the Indiana Psychiatric Illness Interview, Metacognition Assessment Scale–Abbreviated, Movie for the Assessment of Social Cognition, and a large cognitive battery. Compared with those with schizophrenia, participants with ASD had higher self-reflectivity (p = 0.025; odds ratio, 1.38 [1.05–1.86]) in univariable analyses. Metacognitive deficits may be found in ASD with a profile that varies from what is found in schizophrenia. It is possible that methods for enhancing metacognitive abilities during psychiatric rehabilitation may be refined to assist adults with ASD to better manage their own recovery.


  • Open Access

    Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study

    by Julien Dubreucq, Franck Gabayet, Ophélia Godin, Myrtille Andre, Bruno Aouizerate, Delphine Capdevielle, Isabelle Chereau, Julie Clauss-Kobayashi, Nathalie Coulon, Thierry D’amato, et al.

    Recovery is a multidimensional construct that can be defined either from a clinical perspective or from a consumer-focused one, as a self-broadening process aimed at living a meaningful life beyond mental illness. We aimed to longitudinally examine the overlap and mutual distinctions between clinical and personal recovery. Of 1239 people with schizophrenia consecutively recruited from the FondaMental Advanced Centers of Expertise for SZ network, the 507 present at one-year did not differ from those lost to follow-up. Clinical recovery was defined as the combination of clinical remission and functional remission. Personal recovery was defined as being in the rebuilding or in the growth stage of the Stages of Recovery Instrument (STORI). Full recovery was defined as the combination of clinical recovery and personal recovery. First, we examined the factors at baseline associated with each aspect of recovery. Then, we conducted multivariable models on the correlates of stable clinical recovery, stable personal recovery, and stable full recovery after one year. At baseline, clinical recovery and personal recovery were characterized by distinct patterns of outcome (i.e. better objective outcomes but no difference in subjective outcomes for clinical recovery, the opposite pattern for personal recovery, and better overall outcomes for full recovery). We found that clinical recovery and personal recovery predicted each other over time (baseline personal recovery for stable clinical recovery at one year; P = .026, OR = 4.94 [1.30–23.0]; baseline clinical recovery for stable personal recovery at one year; P = .016, OR = 3.64 [1.31–11.2]). In short, given the interaction but also the degree of difference between clinical recovery and personal recovery, psychosocial treatment should target, beyond clinical recovery, subjective aspects such as personal recovery and depression to reach full recovery.